Search research articles
Contact Us
Filters
Showing results (51-60 of 89) with videos related to
Page
of 9
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
November 23, 2025
Novel 4D radiomics applied to dynamic FES PET images to improve prediction of breast cancer response to ER-targeted therapy
Andrew William Chen, Carla R Zeballos Torrez, Lanell M Peterson, et al.
Clinical Nuclear Medicine
|
February 3, 2011
C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy
Evan Y Yu, Mark Muzi, Joy A Hackenbracht, et al.
Breast Cancer Research : BCR
|
February 18, 2025
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer
Natasha B Hunter, Lanell M Peterson, Jennifer M Specht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging
Joseph G Rajendran, David A Mankoff, Finbarr O'Sullivan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2004
18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter
Alexander M Spence, Mark Muzi, David A Mankoff, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 26, 2005
[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure
James G Douglas, Keith J Stelzer, David A Mankoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome
Alexander M Spence, Mark Muzi, Michael M Graham, et al.
Nuclear Medicine and Biology
|
October 9, 2007
Challenges in clinical studies with multiple imaging probes
Kenneth A Krohn, Finbarr O'Sullivan, John Crowley, et al.
Research Square
|
February 5, 2024
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials
Mark Muzi, Lanell M Peterson, Jennifer M Specht, et al.
EJNMMI Research
|
March 27, 2024
Repeatability of <sup>18</sup>F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials
Mark Muzi, Lanell M Peterson, Jennifer M Specht, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 89) with videos related to
Sort By:
Page
of 9
European Journal of Nuclear Medicine and Molecular Imaging
|
November 23, 2025
Novel 4D radiomics applied to dynamic FES PET images to improve prediction of breast cancer response to ER-targeted therapy
Andrew William Chen, Carla R Zeballos Torrez, Lanell M Peterson, et al.
Clinical Nuclear Medicine
|
February 3, 2011
C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy
Evan Y Yu, Mark Muzi, Joy A Hackenbracht, et al.
Breast Cancer Research : BCR
|
February 18, 2025
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer
Natasha B Hunter, Lanell M Peterson, Jennifer M Specht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging
Joseph G Rajendran, David A Mankoff, Finbarr O'Sullivan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2004
18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter
Alexander M Spence, Mark Muzi, David A Mankoff, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 26, 2005
[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure
James G Douglas, Keith J Stelzer, David A Mankoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome
Alexander M Spence, Mark Muzi, Michael M Graham, et al.
Nuclear Medicine and Biology
|
October 9, 2007
Challenges in clinical studies with multiple imaging probes
Kenneth A Krohn, Finbarr O'Sullivan, John Crowley, et al.
Research Square
|
February 5, 2024
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials
Mark Muzi, Lanell M Peterson, Jennifer M Specht, et al.
EJNMMI Research
|
March 27, 2024
Repeatability of <sup>18</sup>F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials
Mark Muzi, Lanell M Peterson, Jennifer M Specht, et al.
Page
of 9